A new narrative review maps how troponin kinetics, inflammatory markers, natriuretic peptides, and emerging molecular ...

KEYTRUDA as Monotherapy Reduced Risk of Disease Progression or Death by 43% for Certain Patients With Advanced or Recurrent ...

Alnylam Pharmaceuticals (NASDAQ:ALNY) outlined early clinical data for brezosiran, an investigational RNA interference ...

Responses were deep and durable, with 65% ongoing at clinical cutoff; Results support continued evaluation of the ...

“Echocardiography is more than pressing a button to take pictures. It means reading blood flow and pressure in a constantly ...